Skip to content

Study · Not a test of the peptide alone · 2023

1 result

Pharmaco-endoscopic therapy for weight regain post-gastric bypass: a case report.

Jarrah M, Mokadem M

Journal of surgical case reports28 Feb 2023

PMID37069846 (opens in a new tab)PMCIDPMC9972808 (opens in a new tab)DOI10.1093/jscr/rjad075 (opens in a new tab)PepBankPUB-37069846
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Liraglutide.

  1. 01HumanNot a test of Liraglutide aloneCase report or seriesEfficacy outcome

    In a woman with weight regain after gastric bypass, adding liraglutide to argon plasma coagulation sessions was followed by significantly more weight loss.

    In plain wordsIn one woman with weight regain after gastric bypass, weight loss increased after liraglutide was added to endoscopic treatment.

    Peptide
    Liraglutide
    Outcome
    DecreaseWeight loss after adding liraglutide to endoscopic therapy
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight

    Source sentences

    Summary
    We then added liraglutide to her APC endo-therapy sessions and subsequentially patient started losing significantly more weight.
    1 context sentence
    Summary · context
    A 53-year-old woman with morbid obesity who responded adequately to gastric-bypass regained significant weight 8 years later.

    In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.